Wellness products company Nature’s Sunshine (NASDAQ: NATR) will be reporting earnings this Thursday after market close. Here’s what to expect.
Nature's Sunshine beat analysts’ revenue expectations last quarter, reporting revenues of $123.8 million, up 4.7% year on year. It was an exceptional quarter for the company, with a beat of analysts’ EPS estimates and a solid beat of analysts’ EBITDA estimates.
Is Nature's Sunshine a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Nature's Sunshine’s revenue to grow 7.9% year on year, improving from the 2% increase it recorded in the same quarter last year.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Nature's Sunshine has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Nature's Sunshine’s peers in the personal care segment, some have already reported their Q1 results, giving us a hint as to what we can expect. Medifast’s revenues decreased 34.3% year on year, beating analysts’ expectations by 9.9%, and Estée Lauder reported revenues up 4.6%, in line with consensus estimates. Medifast traded up 22.8% following the results while Estée Lauder was also up 6%.
Read our full analysis of Medifast’s results here and Estée Lauder’s results here.
Investors in the personal care segment have had steady hands going into earnings, with share prices up 1.8% on average over the last month. Nature's Sunshine is up 13% during the same time and is heading into earnings with an average analyst price target of $33 (compared to the current share price of $27.80).
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
